ACLNCT07185802
Clinical Outcome of Intra-articular Injection of PRP in ACL Injury.
StatusCompleted
PhaseNot applicable
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria shortened, about 5 words Show 8 more changesShow less
- Trial completed
- Interventions modified
- Enrollment target: estimated 52 to confirmed 47
- Primary completion date changed from estimate of Apr 2026 to Apr 5, 2026
- Secondary endpoint revised
- Study description expanded, about 2,913 words
- Site details revised
- Study title shortened, about 6 words
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Visual Analog Scale (VAS ): Change in pain intensity measured by Visual Analog Scale
Timeframe: Baseline, 3 weeks, 8 weeks, and 16 weeks after intervention.
Secondary (1)
Knee Injury and Osteoarthritis Outcome Score (KOOS): Change in functional outcome measured by Knee Injury and Osteoarthritis Outcome Score (KOOS)
Arms and interventions
Group A/Experimental groupExperimental
Will receive PRP and conventional conservative treatment (physical therapy, functional bracing, lifestyle modification)
Group B/Control groupActive comparator
Will receive conventional conservative treatment (physical therapy, functional bracing, lifestyle modification) only
Biologicals: PRP injection
Other: conventional conservative treatment (physical therapy, functional bracing, lifestyle modification)
Sites
1 site in 1 country
- Bangabandhu Sheikh Mujib Medical UniversityDhaka, Bangladesh